The Global Needle-Free Injection System Market Is Witnessing High Growth Owing To the Increasing Launch of Advanced Needle-Free Injection Systems in the World

 Needle-free Injection System Market, by Product Type (Prefilled and Fillable), by Delivery Site (Subcutaneous Injectors, Intramuscular Injectors, and Intradermal Injectors), by Product Lifecycle (Disposable and Reusable), by Technology (Jet-based needle-free injector, Spring-based needle-free injector, and Laser-powered needle-free injector), by Application (Vaccine and Other Biologic Product Delivery, Insulin Delivery, and Others), by End User (Hospitals & Clinics and Home Based Care), and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028.

Market Overview:

Needle-free Injection System Market  technology has the potential to make the administration of medicine safer and more convenient. It reduces the risk of needle stick injuries and eliminates the pain and discomfort of needle injections. Needle-free injection systems can be used to deliver a wide variety of drugs subcutaneously. The technology works by utilizing a compressed gas that is actuated after a small hole has been formed in the skin. When the gas is injected, a narrow jet of fluid is released, which impacts the skin at high speeds. This narrow stream is then pushed through the skin with a precise dose. 

Competitive Landscape:

Major players operating in the global needle-free injection system market include Crossject SA, European Pharma Group, Valeritas, Inc., National Medical Products Inc., INJEX Pharma AG, PenJet Corporation, Medical International Technology, Inc., Bioject Medical Technologies Inc., PharmaJet, Zogenix, Portal Instruments, Inc., Endo International plc, and Antares Pharma, Inc.

Key Market Drivers:

Increasing developments in the global needle-free injection system market are expected to augment the growth of the market. For instance, in October 2021, Enesi Pharma initiated the development of its next-generation vaccination products, which are used for targeting emergent threat pathogens and infectious diseases. One of the major advantages of needle-free injectors is the reduction of the need for training and personnel supervision. In addition, they are easy to store and dispose of. They are also very effective. Despite their cost, they are preferred by many patients and physicians. Moreover, the increasing incidence of chronic diseases in the world is estimated to enhance the growth of the global needle-free injection system market.

 Covid-19 Impact Analysis:

During the COVID-19 pandemic, there have been several developments in the global needle-free injection system market. For instance, in August 2021, Zydus Cadila and PharmaJet partnered in order to announce the approval of Emergency Use Authorization (EUA) for the first plasmid DNA COVID-19 vaccine delivery with a needle-free injection. 

Key Takeaways:

·        North America is expected to dominate the growth of the global needle-free injection system market, owing to the high developments by key players in the region. For instance, in December 2021, Nykode Therapeutics and PharmaJet partnered in order to announce the phase 1/2 medical trial with advanced DNA-based COVID-19 vaccines.

·        Europe is estimated to witness high growth in the global needle-free injection system market, owing to the increasing expansion of market key players in the region. For instance, in May 2021, Enesi pharma achieved a significant milestone in developing thermostable solid-dose live vaccines, to treat Rubella and Measles.